Open AccessOral antifungal therapy: Emerging culprits of cutaneous adverse drug reactions
Author(s) -
Raju G Chaudhary,
Santoshdev P Rathod,
Ashish Jagati,
Dhara Zankat,
Arwinder Kaur Brar,
Bansri Mahadevia
Publication year - 2019
Publication title -
indian dermatology online journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_353_18
Subject(s) - medicine , terbinafine , itraconazole , griseofulvin , incidence (geometry) , dermatology , adverse effect , antifungal drug , observational study , antifungal , physics , optics
Antifungals are one of the most widely used drugs in dermatology practice for dermatophytosis. Oral antifungal therapy against superficial dermatophytosis is generally associated with a low incidence of adverse events in an immunocompetent population. However, lately, cutaneous adverse drugs reactions (CADRs) have been reported with varying incidence rates in the patients on oral antifungal therapy with many uncommon morphological patterns. The present, observational study was conducted over a period of 4 months to report the cases which presented with antifungal therapy-associated CADRs.